Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 7Phase 1/2 4Phase EARLY_PHASE1 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 5Neoplasm Metastasis 2Carcinoma, Renal Cell 2Uveal Melanoma 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Motor Activity 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Carcinoma, Merkel Cell 1Brain Neoplasms 1

Interventions

pembrolizumab 3Oncolytic Virotherapy 3Magnetic Resonance Spectroscopy 3Specimen Handling 2Radiotherapy 2Nivolumab 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2trastuzumab biosimilar HLX02 1sodium thiosulfate 1pertuzumab 1perflutren 1palbociclib 1olaparib 1niraparib 1montelukast 1eribulin 1entrectinib 1cobimetinib 1camrelizumab 1atezolizumab 1apatinib 1alovudine 1alectinib 1X-Rays 1Vinorelbine 1Vincristine 1Vemurafenib 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sarcoma × Ipilimumab × Clear all
NCT03463408 2025-08-11

Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

University of Rochester

Phase EARLY_PHASE1 Active not recruiting
14 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡